In a nutshell This study assessed the effectiveness of Fluxonorm® herbal supplement when combined with standard therapy for lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The authors concluded that the effectiveness of standard therapy was improved by the addition of Fluxonorm® in patients with...
Read More
In a nutshell The authors examined the relationship between prostate size and surgical outcomes following bipolar transurethral enucleation of the prostate (B-TUEP). The authors found that B-TUEP provided symptom relief regardless of prostate size in men with benign prostatic hyperplasia (BPH). Some background BPH is the non-cancerous...
Read More
In a nutshell This study characterized the safety and effectiveness of greenlight photo-selective vaporization of the prostate (GL-PVP) in the treatment of benign prostatic hyperplasia (BPH). The data showed that under real-world conditions, GL-PVP provides a safe, effective, and durable BPH treatment option. Some background Lower urinary tract...
Read More
In a nutshell This study investigated the use of water vapor thermal therapy using the Rezum system as a minimally invasive treatment option for benign prostatic hyperplasia (BPH). The authors concluded that Rezum is a good minimally invasive treatment option that showed promising results for patients with BPH. Some background BPH is a...
Read More
In a nutshell This study compared the safety and effectiveness of bipolar transurethral enucleation of the prostate (BipoLEP) to bipolar transurethral resection of the prostate (B-TURP) in the treatment of benign prostatic hyperplasia (BPH). The data showed that BipoLEP resulted in fewer adverse effects, complications, and faster...
Read More
In a nutshell This study aimed to evaluate a minimally invasive surgical treatment option for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). This study found that the temporary implantable nitinol device (iTIND) is a promising technique for these patients. Some background Benign prostatic...
Read More
In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...
Read More
In a nutshell This study aimed to investigate the effects of combining dutasteride (Avodart) and solifenacin (Vesicare) on sexual function in men being treated for benign prostatic hyperplasia (BPH). This study found that the combination of dutasteride and solifenacin does not alter sexual function for men with BPH. Some...
Read More
In a nutshell This study looked at the use of convective thermal (a form of heat) therapy to treat urinary symptoms in patients with benign prostatic hyperplasia (BPH – an enlarged prostate). The study found that heat therapy is effective in the treatment of BPH symptoms. Some background BPH is an enlarged prostate that may cause bothersome...
Read More
In a nutshell This study looked at the effect of removing an alpha 1-blocker (A1B) from an A1B plus 5 alpha-reductase inhibitor (5ARI) combination therapy on urinary symptoms due to benign prostatic hyperplasia (BPH – an enlarged prostate). The study found that removing an A1B from combination therapy did not affect urinary and bladder...
Read More
In a nutshell This study looked at the effect dutasteride (Avodart) had on testosterone levels, bladder symptoms and testicle size in men with enlarged prostates. The study found that dutasteride increased testosterone which may help with these age-related male symptoms. Some background Benign prostatic hyperplasia (BPH) is an enlarged prostate...
Read MoreIn a nutshell This study looked at the effect of injecting botulinum toxin type A (BTA) into patients to treat enlarged prostate who did not respond to medical therapy such as drug treatment. The study found that BTA injection was safe and effective at reducing several urinary symptoms in patients with enlarged prostates. Some background Benign...
Read More
